Cargando…

Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis

BACKGROUND: The causes, clinical presentations and treatment outcomes of optic neuritis are distinct among different populations. Early diagnosis based on clinical presentations plays an important role in treating optic neuritis patients. OBJECTIVE: The study aimed to determine clinical characterist...

Descripción completa

Detalles Bibliográficos
Autores principales: Hansapinyo, Linda, Vivattanaseth, Chayanee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bentham Open 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131319/
https://www.ncbi.nlm.nih.gov/pubmed/30258505
http://dx.doi.org/10.2174/1874364101812010247
_version_ 1783354081849376768
author Hansapinyo, Linda
Vivattanaseth, Chayanee
author_facet Hansapinyo, Linda
Vivattanaseth, Chayanee
author_sort Hansapinyo, Linda
collection PubMed
description BACKGROUND: The causes, clinical presentations and treatment outcomes of optic neuritis are distinct among different populations. Early diagnosis based on clinical presentations plays an important role in treating optic neuritis patients. OBJECTIVE: The study aimed to determine clinical characteristics, treatment outcomes and predictive factors of treatment outcomes in optic neuritis patients with and without demyelinating disease. METHODS: A retrospective descriptive study of optic neuritis patients carried out between January 2009 and December 2016 was done. Univariate analysis and multivariate logistic regression analysis were used to evaluate the predictive factors of treatment outcomes. RESULTS: Among 150 patients with optic neuritis, 58 patients were diagnosed with Neuromyelitis Optica Spectrum Disease (NMOSD), 23 patients were diagnosed with Multiple Sclerosis (MS) and 69 patients were idiopathic. The age at presentation in the NMOSD group was significantly younger than the MS group and the idiopathic group. The female:male ratio was significantly lower in the idiopathic group than in the NMOSD group. The initial Best Corrected Visual Activity (BCVA) of 20/20-20/60 (p = 0.001) and the idiopathic group (p =0.030) was associated with good visual outcomes. Initial BCVA of < 20/200 (p = 0.009) and the NMOSD group (p < 0.001) was associated with poor visual outcomes. CONCLUSION: NMOSD is a more common cause of optic neuritis than MS in Thai population. Female patients with poor initial VA, poor response to steroids treatment, and presenting recurrent attacks are highly suspicious for NMOSD. Optic neuritis without associated demyelinating disease has a better visual outcome and lower recurrence rate.
format Online
Article
Text
id pubmed-6131319
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Bentham Open
record_format MEDLINE/PubMed
spelling pubmed-61313192018-09-26 Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis Hansapinyo, Linda Vivattanaseth, Chayanee Open Ophthalmol J Ophthalmology BACKGROUND: The causes, clinical presentations and treatment outcomes of optic neuritis are distinct among different populations. Early diagnosis based on clinical presentations plays an important role in treating optic neuritis patients. OBJECTIVE: The study aimed to determine clinical characteristics, treatment outcomes and predictive factors of treatment outcomes in optic neuritis patients with and without demyelinating disease. METHODS: A retrospective descriptive study of optic neuritis patients carried out between January 2009 and December 2016 was done. Univariate analysis and multivariate logistic regression analysis were used to evaluate the predictive factors of treatment outcomes. RESULTS: Among 150 patients with optic neuritis, 58 patients were diagnosed with Neuromyelitis Optica Spectrum Disease (NMOSD), 23 patients were diagnosed with Multiple Sclerosis (MS) and 69 patients were idiopathic. The age at presentation in the NMOSD group was significantly younger than the MS group and the idiopathic group. The female:male ratio was significantly lower in the idiopathic group than in the NMOSD group. The initial Best Corrected Visual Activity (BCVA) of 20/20-20/60 (p = 0.001) and the idiopathic group (p =0.030) was associated with good visual outcomes. Initial BCVA of < 20/200 (p = 0.009) and the NMOSD group (p < 0.001) was associated with poor visual outcomes. CONCLUSION: NMOSD is a more common cause of optic neuritis than MS in Thai population. Female patients with poor initial VA, poor response to steroids treatment, and presenting recurrent attacks are highly suspicious for NMOSD. Optic neuritis without associated demyelinating disease has a better visual outcome and lower recurrence rate. Bentham Open 2018-08-31 /pmc/articles/PMC6131319/ /pubmed/30258505 http://dx.doi.org/10.2174/1874364101812010247 Text en © 2018 Hansapinyo and Vivattanaseth. https://creativecommons.org/licenses/by/4.0/legalcode This is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International Public License (CC-BY 4.0), a copy of which is available at: (https://creativecommons.org/licenses/by/4.0/legalcode). This license permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Ophthalmology
Hansapinyo, Linda
Vivattanaseth, Chayanee
Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis
title Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis
title_full Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis
title_fullStr Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis
title_full_unstemmed Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis
title_short Clinical Characteristics, Treatment Outcomes and Predictive Factors in Optic Neuritis
title_sort clinical characteristics, treatment outcomes and predictive factors in optic neuritis
topic Ophthalmology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6131319/
https://www.ncbi.nlm.nih.gov/pubmed/30258505
http://dx.doi.org/10.2174/1874364101812010247
work_keys_str_mv AT hansapinyolinda clinicalcharacteristicstreatmentoutcomesandpredictivefactorsinopticneuritis
AT vivattanasethchayanee clinicalcharacteristicstreatmentoutcomesandpredictivefactorsinopticneuritis